197 related articles for article (PubMed ID: 38285111)
21. Subjective and objective cognitive functioning among patients with breast cancer: effects of chemotherapy and mood symptoms.
Hsu YH; Chen VC; Hsieh CC; Weng YP; Hsu YT; Hsiao HP; Wang WK; Chen HM; Weng JC; Wu SI; Gossop M
Breast Cancer; 2021 Jan; 28(1):236-245. PubMed ID: 33030667
[TBL] [Abstract][Full Text] [Related]
22. The Effect of Exercise on Cancer-Related Cognitive Impairment and Applications for Physical Therapy: Systematic Review of Randomized Controlled Trials.
Campbell KL; Zadravec K; Bland KA; Chesley E; Wolf F; Janelsins MC
Phys Ther; 2020 Mar; 100(3):523-542. PubMed ID: 32065236
[TBL] [Abstract][Full Text] [Related]
23. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial.
Wefel JS; Lenzi R; Theriault RL; Davis RN; Meyers CA
Cancer; 2004 Jun; 100(11):2292-9. PubMed ID: 15160331
[TBL] [Abstract][Full Text] [Related]
24. Cognitive limitations associated with tamoxifen and aromatase inhibitors in employed breast cancer survivors.
Breckenridge LM; Bruns GL; Todd BL; Feuerstein M
Psychooncology; 2012 Jan; 21(1):43-53. PubMed ID: 20967847
[TBL] [Abstract][Full Text] [Related]
25. Assessing brain volume changes in older women with breast cancer receiving adjuvant chemotherapy: a brain magnetic resonance imaging pilot study.
Chen BT; Sethi SK; Jin T; Patel SK; Ye N; Sun CL; Rockne RC; Haacke EM; Root JC; Saykin AJ; Ahles TA; Holodny AI; Prakash N; Mortimer J; Waisman J; Yuan Y; Somlo G; Li D; Yang R; Tan H; Katheria V; Morrison R; Hurria A
Breast Cancer Res; 2018 May; 20(1):38. PubMed ID: 29720224
[TBL] [Abstract][Full Text] [Related]
26. Effects of exercise on cancer-related cognitive impairment in breast cancer survivors: a scoping review.
Jesús OJ; Luis CP; Matilde MF
Breast Cancer; 2023 Nov; 30(6):885-909. PubMed ID: 37480454
[TBL] [Abstract][Full Text] [Related]
27. Longitudinal impact of yoga on chemotherapy-related cognitive impairment and quality of life in women with early stage breast cancer: a case series.
Galantino ML; Greene L; Daniels L; Dooley B; Muscatello L; O'Donnell L
Explore (NY); 2012; 8(2):127-35. PubMed ID: 22385567
[TBL] [Abstract][Full Text] [Related]
28. Study protocol of the Aerobic exercise and CogniTIVe functioning in women with breAsT cancEr (ACTIVATE) trial: a two-arm, two-centre randomized controlled trial.
Brunet J; Barrett-Bernstein M; Zadravec K; Taljaard M; LeVasseur N; Srikanthan A; Bland KA; Collins B; Kam JWY; Handy TC; Hayden S; Simmons C; Smith AM; Virji-Babul N; Campbell KL
BMC Cancer; 2020 Jul; 20(1):711. PubMed ID: 32736542
[TBL] [Abstract][Full Text] [Related]
29. Protocol for the Exercise, Cancer and Cognition - The ECCO-Study: A Randomized Controlled Trial of Simultaneous Exercise During Neo-/Adjuvant Chemotherapy in Breast Cancer Patients and Its Effects on Neurocognition.
Kiesl D; Kuzdas-Sallaberger M; Fuchs D; Brunner S; Kommenda R; Tischler C; Hornich H; Akbari K; Kellermair J; Blessberger H; Ocenasek H; Hofmann P; Zimmer P; Vosko MR
Front Neurol; 2022; 13():777808. PubMed ID: 35401389
[TBL] [Abstract][Full Text] [Related]
30. Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma.
Schagen SB; van Dam FS; Muller MJ; Boogerd W; Lindeboom J; Bruning PF
Cancer; 1999 Feb; 85(3):640-50. PubMed ID: 10091737
[TBL] [Abstract][Full Text] [Related]
31. Self-reported physical activity behavior of breast cancer survivors during and after adjuvant therapy: 12 months follow-up of two randomized exercise intervention trials.
Schmidt ME; Wiskemann J; Ulrich CM; Schneeweiss A; Steindorf K
Acta Oncol; 2017 Apr; 56(4):618-627. PubMed ID: 28084890
[TBL] [Abstract][Full Text] [Related]
32. Cognitive functioning in breast cancer survivors: a controlled comparison.
Jim HS; Donovan KA; Small BJ; Andrykowski MA; Munster PN; Jacobsen PB
Cancer; 2009 Apr; 115(8):1776-83. PubMed ID: 19224550
[TBL] [Abstract][Full Text] [Related]
33. A mechanistic cohort study evaluating cognitive impairment in women treated for breast cancer.
Vardy JL; Stouten-Kemperman MM; Pond G; Booth CM; Rourke SB; Dhillon HM; Dodd A; Crawley A; Tannock IF
Brain Imaging Behav; 2019 Feb; 13(1):15-26. PubMed ID: 28466438
[TBL] [Abstract][Full Text] [Related]
34. Effect of aerobic exercise on cancer-associated cognitive impairment: A proof-of-concept RCT.
Campbell KL; Kam JWY; Neil-Sztramko SE; Liu Ambrose T; Handy TC; Lim HJ; Hayden S; Hsu L; Kirkham AA; Gotay CC; McKenzie DC; Boyd LA
Psychooncology; 2018 Jan; 27(1):53-60. PubMed ID: 28075038
[TBL] [Abstract][Full Text] [Related]
35. Cognitive functioning after adjuvant chemotherapy and/or radiotherapy for early-stage breast carcinoma.
Donovan KA; Small BJ; Andrykowski MA; Schmitt FA; Munster P; Jacobsen PB
Cancer; 2005 Dec; 104(11):2499-507. PubMed ID: 16247788
[TBL] [Abstract][Full Text] [Related]
36. Potential factors associated with perceived cognitive impairment in breast cancer survivors.
Myers JS; Wick JA; Klemp J
Support Care Cancer; 2015 Nov; 23(11):3219-28. PubMed ID: 25832894
[TBL] [Abstract][Full Text] [Related]
37. Cancer treatment effects on cognition and depression: The moderating role of physical activity.
Bedillion MF; Ansell EB; Thomas GA
Breast; 2019 Apr; 44():73-80. PubMed ID: 30685529
[TBL] [Abstract][Full Text] [Related]
38. Self-reported chemotherapy-related cognitive impairment compared with cognitive complaints following menopause.
Vega JN; Dumas J; Newhouse PA
Psychooncology; 2018 Sep; 27(9):2198-2205. PubMed ID: 29904964
[TBL] [Abstract][Full Text] [Related]
39. Neuropsychological functioning in postmenopausal breast cancer patients treated with tamoxifen or exemestane after AC-chemotherapy: cross-sectional findings from the neuropsychological TEAM-side study.
Schilder CM; Eggens PC; Seynaeve C; Linn SC; Boogerd W; Gundy CM; Beex LV; Van Dam FS; Schagen SB
Acta Oncol; 2009; 48(1):76-85. PubMed ID: 18777410
[TBL] [Abstract][Full Text] [Related]
40. Cognitive impairment following chemotherapy for breast cancer: The impact of practice effect on results.
Cerulla N; Arcusa À; Navarro JB; de la Osa N; Garolera M; Enero C; Chico G; Fernández-Morales L
J Clin Exp Neuropsychol; 2019 Apr; 41(3):290-299. PubMed ID: 30477390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
